343 related articles for article (PubMed ID: 33803478)
1. Microglial Heterogeneity and Its Potential Role in Driving Phenotypic Diversity of Alzheimer's Disease.
Sorrentino S; Ascari R; Maderna E; Catania M; Ghetti B; Tagliavini F; Giaccone G; Di Fede G
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803478
[TBL] [Abstract][Full Text] [Related]
2. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
3. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
[TBL] [Abstract][Full Text] [Related]
6. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
7. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
[TBL] [Abstract][Full Text] [Related]
9. Microglial motility in Alzheimer's disease and after Aβ42 immunotherapy: a human post-mortem study.
Franco-Bocanegra DK; George B; Lau LC; Holmes C; Nicoll JAR; Boche D
Acta Neuropathol Commun; 2019 Nov; 7(1):174. PubMed ID: 31703599
[TBL] [Abstract][Full Text] [Related]
10. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models.
Ma QL; Zhu C; Morselli M; Su T; Pelligrini M; Lu Z; Jones M; Denver P; Castro D; Gu X; Relampagos F; Caoili K; Teter B; Frautschy SA; Cole GM
Front Immunol; 2020; 11():558036. PubMed ID: 33178186
[TBL] [Abstract][Full Text] [Related]
11. The role of P2X7R in neuroinflammation and implications in Alzheimer's disease.
Chen YH; Lin RR; Tao QQ
Life Sci; 2021 Apr; 271():119187. PubMed ID: 33577858
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
Spangenberg EE; Green KN
Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
14. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
[TBL] [Abstract][Full Text] [Related]
15. Microglial activation in Alzheimer's disease.
Schlachetzki JC; Hüll M
Curr Alzheimer Res; 2009 Dec; 6(6):554-63. PubMed ID: 19747160
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains.
Walker DG; Tang TM; Mendsaikhan A; Tooyama I; Serrano GE; Sue LI; Beach TG; Lue LF
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968618
[TBL] [Abstract][Full Text] [Related]
17. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
[TBL] [Abstract][Full Text] [Related]
19. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.
Kaur D; Sharma V; Deshmukh R
Inflammopharmacology; 2019 Aug; 27(4):663-677. PubMed ID: 30874945
[TBL] [Abstract][Full Text] [Related]
20. The role of inflammation in Alzheimer's disease.
Tuppo EE; Arias HR
Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
